ANGELA ROBB: Open Payments
NPI 1295813640 · SIDNEY, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$81 in 4 payments from 3 companies in 2025. Trend: 2023 $31 · 2024 $32 · 2025 $81
Food & beverage: $81
| Company | Payments | Amount |
|---|---|---|
| Xeris Pharmaceuticals, Inc. | 2 | $30 |
| Neurocrine BioSciences, Inc. | 1 | $27 |
| Lilly USA, LLC | 1 | $24 |
Products named: GVOKE HYPOPEN, INGREZZA, MOUNJARO.
Industry payments across NE — which companies pay providers there.
